Mutasynthesis of fluorinated pactamycin analogues and their antimalarial activity
- PMID: 23521145
- PMCID: PMC3663920
- DOI: 10.1021/ol4004614
Mutasynthesis of fluorinated pactamycin analogues and their antimalarial activity
Abstract
A mutasynthetic strategy has been used to generate fluorinated TM-025 and TM-026, two biosynthetically engineered pactamycin analogues produced by Streptomyces pactum ATCC 27456. The fluorinated compounds maintain excellent activity and selectivity toward chloroquine-sensitive and multidrug-resistant strains of malarial parasites as the parent compounds. The results also provide insights into the biosynthesis of 3-aminobenzoic acid in S. pactum.
Figures
References
-
- White FR. Cancer Chemother Rep. 1962;24:75–78. - PubMed
-
- Otoguro K, Iwatsuki M, Ishiyama A, Namatame M, Nishihara-Tukashima A, Shibahara S, Kondo S, Yamada H, Omura S. J Antibiot (Tokyo) 2010;63:381–384. - PubMed
-
- Brodersen DE, Clemons WM, Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. Cell. 2000;103:1143–1154. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
